General MedicationsINJECTIONGeneric
THYPINONE
PROTIRELIN
Standard Dose
0.5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview THYPINONE is listed in Drugs@FDA under application 017638 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient PROTIRELIN Form and strength INJECTABLE;INJECTION - 0.5MG/ML Sponsor ABBOTT Submission history Latest submission status date: 1991-11-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview THYPINONE is listed in Drugs@FDA under application 017638 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PROTIRELIN Form and strength INJECTABLE;INJECTION - 0.5MG/ML Sponsor ABBOTT Submission history Latest submission status date: 1991-11-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.